Market Performance of BioVie Inc. (BIVI)
Trading Activity BioVie Inc. (ticker: BIVI) declined by 3.12 % over the 24‑hour period ending at 10:25 AM Central Europe on Monday, 26 th. The share price is currently around USD 1.24 on major exchanges.
Liquidity and Market Capitalisation The outstanding share supply is 7.5 million. The company’s market capitalisation stands at USD 9.4 million. In the last 24 hours, approximately USD 175.7 k of shares were traded.
Historical Context Since the end of last month, the share price has fallen by 22.98 %. The 200‑day simple moving average is USD 1.51. The 52‑week high was USD 3.79 on 08/12/2026. The 52‑week low was USD 0.82 on 08/06/2026.
Recent Performance of Peer Companies
| Ticker | 24‑hour change | Current price (USD) | Market cap (USD) |
|---|---|---|---|
| NCPL (Netcapital) | –40.36 % | 1.33 | 10.7 million |
| CABR (Caring Brands) | 0 % | 1.05 | 10.9 million |
| EQS (Equus Total Return) | –2.47 % | 0.79 | 11.0 million |
| CTXR (Citius) | +8.63 % | 0.40 | 11.1 million |
| PASG (Passage Bio) | –3.99 % | 3.37 | 10.8 million |
Company Overview
BioVie Inc. is a clinical‑stage biotechnology company headquartered in the United States. The company focuses on discovering, developing, and commercialising therapies for life‑threatening complications associated with liver cirrhosis, with an initial therapeutic target of ascites. BioVie’s website is https://bioviepharma.com/ , and the company’s shares are listed on the Nasdaq stock exchange.
